Kansas City Clincal Oncology Program CCOP

描述(由申请人提供)：堪萨斯城社区临床肿瘤学计划(KCCOP)已经为堪萨斯城大都市区和其他地区的公民提供了超过25年的服务。KCCOP是自1983年以来作为CCOP持续资助的全国27个项目之一。该计划包括一个由社区医院、医生调查人员和行政支持组成的网络，为患者提供广泛的机会，让他们能够在堪萨斯城地区参加国家癌症研究所的临床试验。二十多年来，KCCOP已经超过了治疗、预防和癌症控制试验的最低应计利润要求。KCCOP是一项合作努力，涉及11个堪萨斯城地区的医疗保健组织和50多名内科肿瘤学家、放射肿瘤学家、外科医生和其他专家。该计划隶属于全国各地的主要研究基地，包括西南肿瘤组、放射治疗肿瘤组、妇科肿瘤组、国家外科辅助乳肠计划、MD安德森癌症中心、癌症和白血病B组、罗切斯特大学癌症中心和国家癌症研究所的临床试验支持单位。医疗保健和临床试验环境的变化需要承诺和灵活性。KCCOP拥有一支敬业和经验丰富的员工队伍，强大的领导力和合作精神，为不断变化的时代提供了适当的平衡。该计划监控趋势，并实施持续改进措施。KCCOP在保护患者--他们的安全和健康、福祉和隐私--与通过试验激活、少数群体外联、医生参与以及高度响应和负责任的支持人员提供尽可能广泛的接触之间取得平衡。最近，KCCOP将重点放在低收益调查人员上，为他们提供额外的资源。目标是在明年增加癌症治疗和预防试验的应计项目超过100个学分。

DESCRIPTION (provided by applicant): The Kansas City Community Clinical Oncology Program (KCCOP) has served the citizens of the Kansas City metropolitan area and beyond for more than 25 years. The KCCOP is one of 27 programs in the nation continuously funded as a CCOP since 1983. The program includes a network of community hospitals, physician investigators, and administrative support to provide broad patient access to National Cancer Institute clinical trials in the Kansas City area. For more than two decades, the KCCOP has exceeded the minimum accrual requirements for treatment, prevention, and cancer control trials. The KCCOP is a cooperative effort involving 11 Kansas City area health care organizations and over 50 medical oncologists, radiation oncologists, surgeons, and other specialists. This program is affiliated with major research bases throughout the nation including the Southwest Oncology Group, Radiation Therapy Oncology Group, Gynecologic Oncology Group, National Surgical Adjuvant Breast and Bowel Project, MD Anderson Cancer Center, Cancer & Leukemia Group B, University of Rochester Cancer Center, and the Clinical Trials Support Unit of the National Cancer Institute. Changes in the healthcare and clinical trials environment require commitment and flexibility. The KCCOP has a dedicated and experienced staff, strong leadership, and a collaborative spirit which provide the right balance for changing times. This program monitors trends and implements measures for continuous improvement. The KCCOP balances protecting patients - their safety and health, well-being, and privacy - with providing the broadest possible access through trial activation, minority outreach, physician participation, and a highly responsive and responsible support staff. Recently, the KCCOP has focused on low accruing investigators to provide them with additional resources. Goals are set to increase accrual in the next year to exceed 100 credits for both cancer treatment and prevention trials.